Angiotensin II induces myocardial hypertrophy, fibrosis, and apoptosis after binding to the angiotensin II type I receptor (AT1R), and AT1R antagonists inhibit the fibrosis in the myocardium after MI [4]. The gene discussed is AGTR1; the disease is cardiac hypertrophy.